In addition to these approaches, simultaneously inhibiting mTOR, which exerts immunosuppressive effects on both innate and adaptive immunity, is expected not only to effectively eliminate cancer but also to potentially provide long-term benefits by reducing resistance to cancer treatment and preventing cancer recurrence. The gene discussed is MTOR; the disease is cancer.